Schedule 13G ownership disclosure

Denali Therapeutics Inc

Security class unavailable · CUSIP: 24823R105

Event date: 2020-09-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
11.1600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-20-256415
Form type
SC 13G
Filer
BIOGEN INC.
CIK
CIK 875045
Filed
Sep 28, 2020
Reporting period
Sep 22, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub